# Miguel A. Hernán

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/miguel-a-hernan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 126,533 |
| Field | Advanced Causal Inference Techniques |
| h-index | 121 |
| i10-index | 342 |
| Last Known Institution | Harvard University |
| OpenAlex ID | https://openalex.org/A5084268825 |
| ORCID iD | https://orcid.org/0000-0003-1619-8456 |
| Works | 578 |

## Researcher papers

- [RoB 2: a revised tool for assessing risk of bias in randomised trials](https://scholariq.org/papers/rob-2-a-revised-tool-for-assessing-risk-of-bias-in-randomised-trials/)
- [ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions](https://scholariq.org/papers/robins-i-a-tool-for-assessing-risk-of-bias-in-non-randomised-studies-of/)
- [Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts](https://scholariq.org/papers/primary-prevention-of-cardiovascular-disease-with-a-mediterranean-diet/)
- [Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study](https://scholariq.org/papers/methotrexate-and-mortality-in-patients-with-rheumatoid-arthritis-a-prospective/)
- [Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US](https://scholariq.org/papers/factors-associated-with-death-in-critically-ill-patients-with-coronavirus/)
- [Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses](https://scholariq.org/papers/specifying-a-target-trial-prevents-immortal-time-bias-and-other-self-inflicted/)
- [Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death](https://scholariq.org/papers/effect-of-colonoscopy-screening-on-risks-of-colorectal-cancer-and-related-death/)
- [Activated Injectable Vitamin D and Hemodialysis Survival](https://scholariq.org/papers/activated-injectable-vitamin-d-and-hemodialysis-survival/)
- [Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19](https://scholariq.org/papers/association-between-early-treatment-with-tocilizumab-and-mortality-among/)
- [The Birth Weight "Paradox" Uncovered?](https://scholariq.org/papers/the-birth-weight-paradox-uncovered/)
- [Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study](https://scholariq.org/papers/infection-fatality-risk-for-sars-cov-2-in-community-dwelling-population-of-spain/)
- [Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19](https://scholariq.org/papers/thrombosis-bleeding-and-the-observational-effect-of-early-therapeutic/)

## Researcher topics

- [Advanced Causal Inference Techniques](https://scholariq.org/topics/advanced-causal-inference-techniques/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Statistical Methods and Inference](https://scholariq.org/topics/statistical-methods-and-inference/)
- [Statistical Methods in Clinical Trials](https://scholariq.org/topics/statistical-methods-in-clinical-trials/)
- [Statistical Methods and Bayesian Inference](https://scholariq.org/topics/statistical-methods-and-bayesian-inference/)

## Researcher university

- [Harvard University](https://scholariq.org/institutions/harvard-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.